Long-noded pit viper extracellular vesicle as well as preparation method and application thereof

Extracellular vesicles were extracted from Baihua Snake tissue through enzymatic lysis and gradient centrifugation, which solved the problem of unknown mechanism of Baihua Snake medicinal materials, achieved significant effect of Baihua Snake extracellular vesicles in cardiovascular disease, and provided new treatments Ideas.

CN119060938APending Publication Date: 2024-12-03蕲泰和瑞生物科技(武汉)有限公司
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410992710.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing white flower snake medicinal materials have a wide variety of raw materials, unclear mechanism of action, and it is difficult to achieve precise pharmaceutical production, and the effect of cardiovascular disease treatment is not clear enough.

Method used

Extracellular vesicles with clear structures were extracted from the white flower snake tissue by enzymatic lysis and gradient centrifugation. The enzyme was used to perform enzymatic lysis, and the extracellular vesicles of the white flower snake were obtained and verified that they were in cardiovascular disease. Application.

Benefits of technology

The successfully extracted extracellular vesicles of white-flowered snakes can significantly promote the proliferation of vascular endothelial cells, inhibit apoptosis, promote cell migration and invasion, and provide new ideas for drug research on cardiovascular diseases and effectively prevent and treat cardiovascular diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060938A_ABST
    Figure CN119060938A_ABST
Patent Text Reader

Abstract

The invention provides a preparation method of long-noded pit viper extracellular vesicles, which comprises the following steps: taking long-noded pit viper tissues, adding enzymatic hydrolysate, carrying out enzymolysis, rough filtration, gradient centrifugation and filtration impurity removal, then carrying out ultra-high-speed centrifugation on filtrate, and collecting the obtained precipitate, namely the long-noded pit viper extracellular vesicles. According to the method, the extracellular vesicles with clear structures and complete edges are successfully extracted from the long-noded pit viper tissues; the whole preparation method is simple, does not need complex equipment, adopts modes such as enzymolysis and centrifugation, does not use chemical reagents, and is safe and pollution-free. The prepared long-noded pit viper extracellular vesicles can be successfully transfected into vascular endothelial cells, remarkably promote HUVEC cell proliferation, inhibit HUVEC cell apoptosis and promote cell migration and invasion ability, and play a role in effectively preventing and treating cardiovascular diseases.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and specifically relates to an extracellular vesicle of white snake and a preparation method and application thereof. Background Art

[0002] Cardiovascular diseases include coronary heart disease, cerebrovascular disease, venous thrombosis and pulmonary embolism. Globally, cardiovascular disease mortality accounts for more than 40% of all causes of death. With the gradual acceleration of the aging process of the population, about 17.9 million patients die from cardiovascular diseases each year (WHO report), and the incidence rate is still increasing year by year. Unhealthy lifestyles, excessive stress, obesity, smoking, drinking, staying up late, and eating a diet high in oil and salt will lead to an increase in the incidence of cardiovascular diseases and a gradual trend toward younger people.

[0003] White-flowered snake is a medicinal material with strong characteristics. It can dispel wind, dredge meridians, calm nerves and stop spasms. Modern pharmacological studies have shown that white-flowered snake can also be anti-inflammatory, analgesic, anti-tumor, and immunomodulatory. Chinese patent CN1457827A discloses a Tanxiaokang capsule that has the effect of treating the sequelae of cardiovascular stroke. It is refined through a process of processing, grinding and screening a variety of Chinese medicinal materials, including white-flowered snake. However, its raw materials are of various types, the mechanism of action is unclear, and the specific functional factors cannot be known, which poses certain difficulties for subsequent precision medicine.

[0004] Therefore, it is urgent to conduct research on this special medicinal material, white flower snake, to find out its specific functional factors, which is extremely important for improving drug efficacy and precision medicine. Summary of the invention

[0005] In view of this, the present invention provides an extracellular vesicle of Snakehead acanthus and a preparation method and application thereof. By obtaining its extracellular vesicle and conducting relevant verification, this functional factor is obtained, which provides a new idea for the research of cardiovascular disease-related drugs.

[0006] In order to achieve the above object, the present invention adopts the following technical solutions:

[0007] A method for preparing extracellular vesicles of white-flowered snakes is as follows: taking white-flowered snake tissue, adding enzymatic hydrolysis solution for enzymatic hydrolysis, coarse filtration, gradient centrifugation, filtering and removing impurities, and then subjecting the filtrate to ultrahigh-speed centrifugation, and collecting the obtained precipitate, which is the extracellular vesicles of white-flowered snakes.

[0008] Furthermore, the enzymatic hydrolysis solution includes collagenase D and endonuclease.

[0009] Furthermore, the concentration of the collagenase D is 1 to 5 mg / mL, and the concentration of the endonuclease is 0.5 to 3 mg / mL.

[0010] In some specific embodiments, preferably, the concentration of collagenase D is 2 mg / mL, and the concentration of endonuclease is 1 mg / mL.

[0011] Furthermore, the material-liquid ratio of the snake tissue to the enzymolysis solution is 1:(3-5); the white-flowered snake tissue is soaked in a PBS solution to soften it before enzymolysis, the enzymolysis time is 0.5-3h, and the enzymolysis temperature is 35-39°C.

[0012] In some specific embodiments, preferably, the material-liquid ratio of the snake tissue to the enzymatic hydrolysis solution is 1:5; the enzymatic hydrolysis time is 2 hours, and the enzymatic hydrolysis temperature is 37°C.

[0013] Furthermore, the specific steps of the gradient centrifugation are as follows: first centrifuge at 800-1200g for 5-15min, take the supernatant, then centrifuge at 2500-3500g for 25-35min, take the supernatant, and finally centrifuge at 10000g-15000g for 25-65min.

[0014] In some specific embodiments, preferably, the specific steps of the gradient centrifugation are as follows: first centrifuge at 1000g for 10 min, take the supernatant, then centrifuge at 3000g for 30 min, take the supernatant, and finally centrifuge at 12000g for 30 min.

[0015] Furthermore, the specific steps of the ultra-high speed centrifugation are as follows: centrifuge at 100,000 g for 60 to 120 min at 4° C., remove the supernatant, add PBS solution to dissolve, and centrifuge again at 100,000 g for 60 to 120 min.

[0016] In some specific embodiments, preferably, the ultra-high speed centrifugation comprises the following specific steps: centrifuging at 100,000 g for 60 min at 4° C., removing the supernatant, adding PBS solution to dissolve, and centrifuging again at 100,000 g for 60 min.

[0017] Furthermore, the white snake tissue includes fresh white snake tissue, dried white snake tissue, and processed white snake tissue; the coarse filtration adopts any one of gauze, screen, and filter paper filtration; and the filtration and impurity removal adopts 0.2-0.5 μm filter membrane for filtration.

[0018] The extracellular vesicles of Snakehead snake obtained by the above preparation method.

[0019] The above-mentioned application of the extracellular vesicles of Snakehead acanthus in preventing and treating cardiovascular diseases includes hypertension, heart failure and atherosclerosis.

[0020] The above-mentioned application of the extracellular vesicles of the white-flowered snake in the preparation of products for preventing and treating cardiovascular diseases, the product types include food, health products, and medicines.

[0021] Compared with the prior art, the present invention has the following beneficial effects:

[0022] The present invention successfully extracted extracellular vesicles (average particle size of 155.1 nm) with clear structure and complete edges from the tissue of white flower snake; the overall preparation method is simple, does not require complex equipment, adopts enzymatic hydrolysis and centrifugation, does not use chemical reagents, and is safe and pollution-free. The prepared white flower snake extracellular vesicles can be successfully transfected into the interior of vascular endothelial cells, significantly promote HUVEC cell proliferation, inhibit HUVEC cell apoptosis (after incubation at room temperature for 15 minutes, the cell apoptosis rate is as low as 1.4%, while the control group is 3.39%), promote cell migration and invasion ability, and play an effective role in preventing and treating cardiovascular diseases. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 This is a graph showing the particle size detection results of the extracellular vesicles of Snakehead acanthus prepared in Example 1 of the present invention.

[0024] Figure 2 This is a graph showing the electron microscopic detection results of the extracellular vesicles of the white-flowered snake prepared in Example 1 of the present invention.

[0025] Figure 3 This is a graph showing the results of laser confocal microscopy detection of the extracellular vesicles of Snakehead acanthus prepared in Example 1 of the present invention and the PBS solution control group.

[0026] Figure 4 The results of the cell proliferation experiment of the extracellular vesicles of Snake prepared in Example 1 of the present invention and the PBS solution control group are shown; wherein A is a fluorescence microscope field of view, and B is an EdU quantification diagram.

[0027] Figure 5 This is a graph showing the results of apoptosis experiments of the extracellular vesicles of Snakehead acanthocephala prepared in Example 1 of the present invention and the PBS solution control group.

[0028] Figure 6 The results of the cell scratch experiment of the extracellular vesicles of Snakehead acanthocephala prepared in Example 1 of the present invention and the PBS solution control group are shown; wherein A is a microscope field image, and B is a scratch width quantification image.

[0029] Figure 7 These are the results of the cell invasion experiment of the extracellular vesicles of Snakehead acanthocephala prepared in Example 1 of the present invention and the PBS solution control group; wherein A is a microscope field image, and B is an invasion quantification image. DETAILED DESCRIPTION

[0030] The present invention is further described in detail below in conjunction with specific embodiments so that those skilled in the art can understand the present invention more clearly.

[0031] Sources and physical and chemical parameters of key test materials:

[0032] The white snake material came from a local pharmacy.

[0033] Collagenase D and endonuclease I were purchased from Roche.

[0034] The process for preparing extracellular vesicles of white snake of the present invention is specifically as follows:

[0035] S1. Take the white flower snake material, soak it in PBS solution to soften the tissue, then cut it into small pieces, add enzymatic solution and incubate it in a shaker at 35-39℃ for 0.5-3h, filter it with gauze to obtain the coarse filtrate.

[0036] S2. Centrifuge the crude filtrate at 800-1200g for 5-15min and take the supernatant; then centrifuge at 2500-3500g for 25-35min and take the supernatant; finally centrifuge at 10000g-15000g for 25-65min and take the supernatant; filter the supernatant through a 0.2-0.5 microporous filter membrane to obtain a refined filtrate.

[0037] S3. Centrifuge the seminal filtrate at 100,000 to 150,000 g for 60 to 120 min at 4° C. and remove the supernatant; add PBS solution to dissolve, centrifuge again at 100,000 to 150,000 g for 60 to 120 min, and remove the supernatant; then add pre-cooled PBS solution to resuspend, and obtain the extracellular vesicle solution of Snake.

[0038] Among them, the enzymatic hydrolysis solution of step S1 contains 1-5 mg / mL collagenase D and 0.5-3 mg / mL nuclease I, and the material-liquid ratio of the snake tissue to the enzymatic hydrolysis solution during enzymatic hydrolysis is 1:(3-5); the PBS solution of steps S1 and S3 contains 5-15 mM Na2HPO4, 135-145 mM NaCl, 1-5 mM NaH2PO4, and the pH is 7.4.

[0039] In the present application, soaking and softening the white flower snake tissue in advance is beneficial to the subsequent enzymatic hydrolysis process; the functions of collagenase D and endonuclease I in the enzymatic hydrolysis solution are to dissociate the collagen in the snake meat tissue to loosen the structure, and to reduce the cell clumps caused by DNA adhesion during the enzymatic hydrolysis process, which is more conducive to the release of extracellular vesicles; gradient centrifugation plays a role in gradually removing tissue residues, cell fragments, and super-large vesicles.

[0040] Example 1

[0041] This embodiment provides an extracellular vesicle of white snake and a preparation method and application thereof. The specific preparation method is as follows:

[0042] S1. Take the snake material, add PBS solution (10mM Na2HPO4, 140mM NaCl, 3mM NaH2PO4, pH 7.4) and soak for 2h to soften the tissue, then cut into 2×2×2mm small pieces, add enzymatic solution (collagenase D concentration is 2mg / mL, nuclease I concentration is 1mg / mL) according to the material-liquid ratio of snake tissue to enzymatic solution of 1:5, and then place it in a 37℃ shaker for incubation for 2h, filter with gauze to obtain the coarse filtrate.

[0043] S2. Centrifuge the crude filtrate at 1000g for 10 min and take the supernatant; then centrifuge at 3000g for 30 min and take the supernatant; finally centrifuge at 12000g for 30 min and take the supernatant; filter the supernatant through a 0.22 microporous filter membrane to obtain a refined filtrate.

[0044] S3. Centrifuge the seminal filtrate at 100,000 g for 60 min at 4°C and remove the supernatant; add PBS solution (10 mM Na2HPO4, 140 mM NaCl, 3 mM NaH2PO4, pH 7.4) to dissolve, centrifuge again at 100,000 g for 60 min, remove the supernatant; then add pre-cooled PBS solution to resuspend, and obtain the extracellular vesicle solution of Snake.

[0045] Furthermore, in order to understand the morphological structure and functional characteristics of the extracellular vesicles of Snakehead snake prepared in Example 1, the following experiments were conducted.

[0046] Morphological identification

[0047] 1. Particle size detection: Take 10 μL of the extracellular vesicle solution of Snakehead acanthus obtained in Example 1 and add it to a nanoparticle analyzer (NTA) for particle size detection. The results are as follows: Figure 1 As shown: The average particle size of the particles in the extracellular vesicle solution of white snake is 155.1nm, and the particle concentration is 2.6×10 11 Particles / ml.

[0048] 2. Electron microscopy: 10 μL of the extracellular vesicle solution of Snakehead acanthocephala obtained in Example 1 was placed on a copper mesh, fixed with acetic glutaraldehyde, and observed under a transmission electron microscope after natural drying. Figure 2 As shown, there are hemispherical nanostructures with a concave middle and raised edges in the extracellular vesicles of Snake, and the particle size is consistent with the NTA detection results.

[0049] Figure 1 , 2 The identification results showed that extracellular vesicles were successfully prepared from the white snake tissue using the method provided by the present invention.

[0050] Functional properties research

[0051] 1. Cell phagocytosis experiment

[0052] (1) Extracellular vesicle staining: 20 μL of the extracellular vesicles of the snake obtained in Example 1 were taken, diluted with PBS solution, and mixed with PKH26 membrane fluorescent dye (purchased from Sigma-Aldrich) for 5 min, and then serum was added to terminate the reaction; then, the free dye was removed by ultracentrifugation at 100000 g for 1 h, and pre-cooled PBS solution was added to resuspend and collect the extracellular vesicles of the snake marked with red fluorescence.

[0053] (2) Co-incubation: Place the slides and human umbilical vein endothelial cells (HUVEC) in a 24-well plate, add PBS solution and extracellular vesicles of Snakehead acanthus according to the group, incubate in a 37°C, 5% CO2 incubator overnight, and then discard the culture medium; add 4% paraformaldehyde to incubate at room temperature for 10 min to fix the cells and then discard; then add 4',6-diamidino-2-phenylindole dihydrochloride solution (DAPI) to incubate in the dark for 10 min to stain the cell nucleus and then discard; then turn the slide upside down on a slide with anti-fluorescence quencher and seal the slide; finally, place the slide under a laser confocal microscope to observe the fluorescence.

[0054] Confocal microscopy field of view Figure 3 As shown in the figure, the DAPI column is the cell nucleus stained with blue fluorescence, the PKH26 column is the extracellular vesicles stained with red fluorescence, and the Merge column is the picture after the DAPI column and the PKH26 column are fused. From the fused picture, it can be seen that there is no red fluorescence in the PBS control group, while most of the red fluorescence in the extracellular vesicle group of the white flower snake appears around the blue fluorescence, indicating that the extracellular vesicles of the white flower snake are phagocytosed and absorbed by HUVEC cells and enter the cell to reach the periphery of the cell nucleus.

[0055] 2. Cell proliferation assay (EDU)

[0056] HUVEC cells were plated in 6-well plates, and PBS solution and extracellular vesicle solution of white snake were added according to the grouping. The plates were then placed in a 37°C, 5% CO2 incubator and incubated overnight. BeyoClick TM The EdU working solution in the EdU cell proliferation detection kit (purchased from Biyuntian Biotechnology) was continued to be incubated for 3 hours; after discarding the culture medium, 4% paraformaldehyde fixative was added, incubated at room temperature for 15 minutes and then discarded; then, 0.3% TritonX-100 permeabilization solution was added and continued to be incubated for 10 minutes and then discarded; 500 μL Click reaction solution was added to each well, incubated in the dark for 30 minutes and then discarded; finally, DAPI was added to stain the cell nucleus and the fluorescence was observed under a fluorescence microscope.

[0057] Fluorescence microscopy field of view Figure 4A, the blue fluorescence of the DAPI row represents the nuclei of all cells, the green fluorescence of the EdU row represents the cells that proliferated during the 3h incubation, and the Merge row is a fluorescence effect diagram of all cell nuclei interwoven with the proliferated cells. EdU quantification diagram ( Figure 4 B) It can be seen that the EdU / DAPI ratio increased significantly after extracellular vesicle treatment in Snakehead acanthocephala compared with the control group.

[0058] 3. Cell apoptosis experiment

[0059] HUVEC cells treated with PBS solution and Snake extracellular vesicles overnight were digested and collected, resuspended in PBS solution, and then 5 μL FITC and PI solutions (purchased from Solebow Biotechnology) were added in sequence, incubated at room temperature for 15 minutes, and then the cell suspension was placed in a flow tube for detection.

[0060] The flow cytometry results are as follows Figure 5 As shown, compared with the control group (apoptosis rate 3.39%), the apoptosis rate of HUVEC cells was significantly reduced (1.4%) after treatment with extracellular vesicles of Snakehead acanthus.

[0061] 4. Cell scratch test

[0062] HUVEC cells were seeded into 6-well plates and cultured in a 37°C 5% CO2 incubator until the cell confluence reached about 80%. Uniform vertical lines were drawn in the wells with a pipette tip. Dead cells produced by the scratches were washed away with PBS solution, and complete culture medium containing PBS solution and extracellular vesicles of Snake was added, and culture was continued for 0, 24, 48, and 72 hours. After discarding the culture medium, the cell migration was observed under a microscope.

[0063] Microscope field of view ( Figure 6 A) showed that the width of cells scratched by the gun tip in the PBS group gradually decreased; compared with the PBS group, the migration speed of HUVEC cells treated with extracellular vesicles of white flower snake was faster; the scratch width quantification diagram ( Figure 6 B) more intuitively found that the extracellular vesicles of white snake significantly promoted the migration speed of HUVEC cells.

[0064] 5. Cell invasion assay

[0065] HUVEC cells were seeded into the chamber of a Transwell plate covered with matrix gel, and PBS solution and Snake extracellular vesicles were added according to the groups, and then cultured in a 37°C, 5% CO2 incubator for 24 hours; after discarding the culture medium, 4% paraformaldehyde was added to fix the cells for 15 minutes and then discarded; crystal violet solution was then added to the plate at room temperature and away from light for 10 minutes, and then PBS was added to wash away the excess dye, and finally the cell invasion was observed under a microscope.

[0066] Microscope field of view ( Figure 7 A) showed that compared with the PBS blank group, the number of HUVEC cells in the basal medium treated with white flower snake extracellular vesicles invading the complete medium increased significantly. Quantification diagram ( Figure 7 B) shows that compared with the control group, the relative invasion rate of HUVEC downward invasion was significantly increased after treatment with extracellular vesicles of Snakehead Snake (relative invasion rate was 1.347%).

[0067] In summary, the present invention provides a method for preparing extracellular vesicles of white-flowered snakes and their application in preventing and treating cardiovascular diseases. The preparation method provided by the present invention successfully extracted extracellular vesicles with clear structure and complete edges from white-flowered snake tissues; and they can be successfully transfected into vascular endothelial cells, significantly promoting HUVEC cell proliferation, inhibiting HUVEC cell apoptosis, promoting cell migration and invasion, and playing an effective role in preventing and treating cardiovascular diseases.

[0068] The specific raw materials not described in the present invention are all existing materials and can be directly purchased from the market.

[0069] The above are only preferred embodiments of the present invention and are not intended to limit the protection scope of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing extracellular vesicles of Snakehead acanthus, It is characterized in that The preparation method is as follows: taking white flower snake tissue, adding enzymatic hydrolysis solution for enzymatic hydrolysis, coarse filtration, gradient centrifugation, filtering and removing impurities, and then ultra-high-speed centrifugation of the filtrate to collect the obtained precipitate, which is the white flower snake extracellular vesicle.

2. The method according to claim 1, It is characterized in that The enzymatic hydrolysis solution comprises collagenase D and endonuclease.

3. The method according to claim 2, It is characterized in that The concentration of the collagenase D is 1-5 mg / mL, and the concentration of the endonuclease is 0.5-3 mg / mL.

4. The method according to claim 2, It is characterized in that The material-liquid ratio of the white flower snake tissue to the enzymolysis solution is 1:(3-5); the white flower snake tissue is soaked in a PBS solution to soften it before enzymolysis, the enzymolysis time is 0.5-3h, and the enzymolysis temperature is 35-39°C.

5. The method according to claim 1, It is characterized in that The specific steps of the gradient centrifugation are as follows: first centrifuge at 800-1200g for 5-15min, take the supernatant, then centrifuge at 2500-3500g for 25-35min, take the supernatant, and finally centrifuge at 10000g-15000g for 25-65min.

6. The method according to claim 1, It is characterized in that The specific steps of the ultra-high speed centrifugation are as follows: centrifuge at 100,000-150,000 g for 60-120 min at 4° C., remove the supernatant, add PBS solution to resuspend, and centrifuge again at 100,000-150,000 g for 60-120 min.

7. The method according to claim 1, It is characterized in that The white snake tissue includes fresh white snake tissue, dried white snake tissue and processed white snake tissue; the coarse filtration adopts any one of gauze, screen and filter paper filtration; the filtration and impurity removal adopts 0.2-0.5 μm filter membrane for filtration.

8. The extracellular vesicles of Snakehead acanthus obtained by the preparation method according to any one of claims 1 to 7.

9. Use of the extracellular vesicles of Snakehead snake according to claim 8 in preventing and treating cardiovascular diseases, It is characterized in that The cardiovascular diseases include hypertension, heart failure, and atherosclerosis.

10. Use of the extracellular vesicles of Snakehead acanthus according to claim 8 in the preparation of a product for preventing and treating cardiovascular diseases, It is characterized in that The product types include food, health products, and medicines.

Citation Information

Cited By

  • Application of chlorogenic acid in preparation of medicine for treating atherosclerotic aortic dissection

    CN122424170A